🔎 Trials Near Me

Domov › Burkittov limfom › Pennsylvania › Philadelphia

Klinične študije za Burkittov limfom v Philadelphia, PA

16 študij za Burkittov limfom išče udeležence na lokacijah v Philadelphia in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

Vključevanje udeležencevFaza 3
  • Children's Hospital of Philadelphia (Data Collection Only), Philadelphia
Starost 1 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT07223021

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

Vključevanje udeležencevFaza 1
  • Children's Hospital of Philadelphia, Philadelphia
Starost 0–18 · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT06173518

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Vključevanje udeležencevFaza 2
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi stran
366 Days – 46 Years · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Vključevanje udeležencevFaza 3
  • University of Pennsylvania/Abramson Cancer Center, Philadelphia
  • Thomas Jefferson University Hospital, Philadelphia
Starost 18–39 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT03150693

Blinatumomab Consolidation in Real World

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
  • University of Pennsylvania, Philadelphia
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07117136

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Vključevanje udeležencevOpazovalna študija
  • Children's Hospital of Philadelphia, Philadelphia
Starost 0–38 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06131801

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Vključevanje udeležencevFaza 2
  • Children's Hospital of Philadelphia, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi stran
365 Days · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06317662

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Vključevanje udeležencevFaza 1/2
  • Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia
6 Months – 25 Years · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT06395103

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Vključevanje udeležencevFaza 2
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi stran
Starost 1–30 · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Vključevanje udeležencevFaza 3
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi stran
365 Days – 25 Years · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT03959085

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Vključevanje udeležencevFaza 2
  • Children's Hospital of Philadelphia, Philadelphia
Starost 7–25 · Vsi spoli · Posodobljeno 19. avg. 2026 · NCT05082519

CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

Vključevanje udeležencev
  • Children's Hospital of Philadelphia, Philadelphia
Do 25 let · Vsi spoli · Posodobljeno 8. jul. 2026 · NCT03810196

Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)

Vključevanje udeležencevFaza 1/2
  • Children's Hospital of Philadelphia, Philadelphia
Starost 0–29 · Vsi spoli · Posodobljeno 26. maj 2026 · NCT05480449

Co-administration of CART22-65s and huCART19 for B-ALL

Vključevanje udeležencevFaza 1/2
  • Children's Hospital of Philadelphia, Philadelphia
Do 29 let · Vsi spoli · Posodobljeno 27. mar. 2026 · NCT05674175

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

Vključevanje udeležencevFaza 1/2
  • Children's Hospital of Philadelphia, Philadelphia
Starost 15–50 · Vsi spoli · Posodobljeno 9. sep. 2025 · NCT04150497

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

Vključevanje udeležencevFaza 2
  • Alfred I. duPont Hospital for Children - Nemours Deleware, Wilmington · 25 mi stran
Starost 1–25 · Vsi spoli · Posodobljeno 4. maj 2025 · NCT03509961

Študije za Burkittov limfom v drugih mestih

Druge študije v Philadelphia

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.